Trexquant Investment’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,129
| Closed | -$1.2M | – | 1546 |
|
|
2024
Q4 | $1.2M | Buy |
+14,129
| New | +$1.2M | 0.01% | 1041 |
|
|
2023
Q4 | – | Sell |
-17,450
| Closed | -$1.22M | – | 1421 |
|
|
2023
Q3 | $1.22M | Buy |
+17,450
| New | +$1.22M | 0.03% | 672 |
|
|
2023
Q2 | – | Sell |
-22,732
| Closed | -$1.4M | – | 1436 |
|
|
2023
Q1 | $1.4M | Sell |
22,732
-1,223
| -5% | -$75.4K | 0.04% | 590 |
|
|
2022
Q4 | $1.85M | Buy |
+23,955
| New | +$1.85M | 0.05% | 430 |
|
|
2022
Q1 | – | Sell |
-8,508
| Closed | -$321K | – | 1348 |
|
|
2021
Q4 | $321K | Buy |
8,508
+1,993
| +31% | +$75.2K | 0.02% | 879 |
|
|
2021
Q3 | $215K | Buy |
+6,515
| New | +$215K | 0.02% | 922 |
|
|
2020
Q3 | – | Sell |
-10,102
| Closed | -$831K | – | 1188 |
|
|
2020
Q2 | $831K | Sell |
10,102
-19,018
| -65% | -$1.56M | 0.06% | 459 |
|
|
2020
Q1 | $1.71M | Buy |
29,120
+26,809
| +1,160% | +$1.58M | 0.12% | 252 |
|
|
2019
Q4 | $239K | Sell |
2,311
-14,758
| -86% | -$1.53M | 0.01% | 840 |
|
|
2019
Q3 | $345K | Buy |
+17,069
| New | +$345K | 0.03% | 578 |
|
|
2018
Q1 | – | Sell |
-22,911
| Closed | -$128K | – | 1065 |
|
|
2017
Q4 | $128K | Buy |
+22,911
| New | +$128K | 0.01% | 992 |
|